Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

TG Therapeutics, Inc. - Common Stock (NQ: TGTX )

37.06 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about TG Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
(TGTX) - Analyzing TG Therapeutics's Short Interest
Via Benzinga
Peering Into TG Therapeutics's Recent Short Interest
Via Benzinga
Why TG Therapeutics Stock Was Rocketing Higher This Week
The company raised guidance for sales of its drug for relapsing multiple sclerosis. 
Via The Motley Fool
Why AMD Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
(TGTX) - Analyzing TG Therapeutics's Short Interest
Via Benzinga
Earnings Preview For TG Therapeutics
Via Benzinga
TGTX Stock Earnings: TG Therapeutics Misses EPS, Beats Revenue for Q1 2024
TGTX stock results show that TG Therapeutics missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. 
Via InvestorPlace
TG Therapeutics stock just rallied 30%: what happened?
TG Therapeutics Inc (NASDAQ: TGTX) is up 30% on Wednesday even though it reported a wider-than-expected per-share loss for its fiscal first quarter. 
Via Talk Markets
Powell Industries Posts Upbeat Results, Joins A10 Networks, Garmin, DuPont And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
Why Is Multiple Sclerosis-Focused TG Therapeutics Stock Trading Higher Today?
TG Therapeutics exceeds expectations with Q4 2023 revenues of $43.97M. Briumvi's success in the U.S., Europe launch, and new patents drive optimism. TGTX shares surge 
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
How Is The Market Feeling About TG Therapeutics?
Via Benzinga
Looking Into TG Therapeutics's Recent Short Interest
Via Benzinga
HC Wainwright & Co. Maintains Buy Rating for TG Therapeutics: Here's What You Need To Know
Via Benzinga
Why Bumble Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of Bumble Inc. (NASDAQ: BMBL) fell sharply during Wednesday’s session following weak quarterly results. 
Via Benzinga
TG Therapeutics Soars On In-Line Report; Is The Biotech Rally Buoying Shares?
The company reported in-line sales for the fourth quarter, but shares soared by double digits. 
Via Investor's Business Daily
Advance Auto Parts Reports Q4 Results, Joins B&G Foods, Vipshop, ADT And Other Big Stocks Moving Higher On Wednesday
U.S. stocks were lower, with the Dow Jones index falling around 100 points on Wednesday. 
Via Benzinga
Topics Stocks
Exposures US Equities
Earnings Scheduled For February 28, 2024
Companies Reporting Before The Bell • ICL Group (NYSE:ICL) is likely to report quarterly earnings at $0.08 per share on revenue of $1.69 billion. 
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
7 Exciting Stocks Poised for Explosive Growth in Key Sectors
These stocks to buy for growth already have a strong growth story. If they reach their potential investors could see some dynamic returns. 
Via InvestorPlace
Stock Market Rally Rebounds; Nvidia, Tesla, JPMorgan, Bitcoin ETFs In Focus: Weekly Review
The major indexes and leading stocks rebounded. Bitcoin ETFs fell in their debut. 
Via Investor's Business Daily
Topics ETFs
Why WD-40 Shares Are Trading Higher By Over 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of WD-40 Company (NASDAQ: WDFC) rose sharply during Wednesday’s session after the company reported better-than-expected first-quarter results. 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Veradigm, Aehr Test Systems, Saratoga Investment And Other Big Stocks Moving Lower On Wednesday
U.S. stocks traded slightly higher, with the Dow Jones index gaining over 20 points on Wednesday. Shares of Veradigm Inc. (NASDAQ: MDRX) shares fell sharply during Wednesday’s session. 
Via Benzinga
Topics Stocks
Exposures US Equities
TG Therapeutics Adds To Its 225% Sprint After MS Drug Crushes Sales Estimates
The company makes a treatment for relapsing forms of multiple sclerosis. 
Via Investor's Business Daily
Why Is Multiple Sclerosis Focused TG Therapeutics Stock Trading Higher Today?
TG Therapeutics Inc (NASDAQ: TGTX) reported preliminary BRIUMVI U.S.  
Via Benzinga
Why Aehr Test Systems Shares Are Trading Lower By 15%; Here Are 20 Stocks Moving Premarket
Shares of Aehr Test Systems (NASDAQ: AEHR) shares fell sharply in pre-market trading after the company lowered its full-year revenue guidance. The company said revenue will likely be impacted by an... 
Via Benzinga
PriceSmart Posts Upbeat Earnings, Joins SMART Global, Intuitive Surgical And Other Big Stocks Moving Higher In Wednesday's Pre-Market Session
U.S. stock futures were higher this morning, with the Nasdaq futures gaining around 60 points on Wednesday. 
Via Benzinga
Grayscale Bitcoin Trust, Coinbase, TG Therapeutics, Aehr Test Systems, Tesla: Why These 5 Stocks Are On Investors' Radars Today
U.S. stock indices were mixed at the end of Tuesday with the Dow Jones falling nearly 160 points to 37,525.16, a decline of 0.42%. The S&P 500 followed dropping 0.15% to 4,756.50. The Nasdaq gained... 
Via Benzinga
Topics Stocks
Exposures US Equities
Why Precision BioSciences Stock Is Up Today
Precision BioSciences, Inc. (NASDAQ: DTIL) shares are trading higher Tuesday after the company announced it has signed a licensing agreement wit 
Via Benzinga
What's Going On With TG Therapeutics Stock?
TG Therapeutics, Inc. (NASDAQ: TGTX) shares are trading lower Tuesday, though the stock remains up 18% over the past five days. Here's a look at what's going on. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.